🔗 Permalink

Inventor profile of:

Herbert K. Lyerly

City:

Durham, North Carolina

Country:

United States

Published Applications:

Last publication date:

2021-10-28

Top Assignees for applications by Herbert K. Lyerly

The entities that hold a legal rights for patent applications filed by inventor Lyerly Herbert K.:

DUKE UNIVERSITY 13 Durham, NC United States

Recent patent applications by Lyerly Herbert K.

Herbert K. Lyerly from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-10-28

US20210330773A1

Human necessities

VACCINES AGAINST ANTIGENS INVOLVED IN THERAPY RESISTANCE AND METHODS OF USING SAME

#2 | 2021-03-18

US20210077606A1

Human necessities

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

#3 | 2021-03-11

US20210069309A1

Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

#4 | 2019-01-24

US20190022204A1

Human necessities

Cancer vaccines and methods of delivery

#5 | 2018-12-06

US20180344824A1

Human necessities

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

#6 | 2018-11-15

US20180326030A1

Human necessities

Vaccines against an oncogenic isoform of ESR1 and methods of using the same

#7 | 2018-11-01

US20180311329A1

Human necessities

Vaccines against antigens involved in therapy resistance and methods of using same

#8 | 2018-10-04

US20180282736A1

Chemistry; metallurgy

HER3 VACCINE VECTOR COMPOSITIONS AND METHODS OF USING THE SAME

#9 | 2018-04-05

US20180094050A1

Chemistry; metallurgy

Vaccines against HER3 antigens and methods of using the same

#10 | 2018-04-05

US20180092989A1

Human necessities

Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same

#11 | 2017-07-13

US20170196953A1

Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME

#12 | 2017-07-13

US20170196952A1

Human necessities

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

#13 | 2014-12-25

US20140377261A1

Human necessities

Vaccines against antigens involved in therapy resistance and methods of using same

InventorID:

1014168 ⎘